US4131971040
US4131971040
Harmony Biosciences Holdings, I
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 868.453.000 | 714.734.000 | 21.5% |
| Cost of Revenue | 198.342.000 | 156.815.000 | 26.5% |
| Gross Profit | 670.111.000 | 557.919.000 | 20.1% |
| 461.642.000 | 367.093.000 | 25.8% | |
| Operating Income | 208.469.000 | 190.826.000 | 9.2% |
| Pretax Income | 215.064.000 | 191.804.000 | 12.1% |
| Net Income Common Stockholders | 158.687.000 | 145.493.000 | 9.1% |
| -- | -- | -- | |
| -- | -- | -- |